DesirableTP53 mutation or strong nuclear expression of p53 in > 10% of tumor cellsMethylation profile of astrocytoma, IDH mutantAstrocyte differentiation by morphology Louis et al. (2021). This evidence concerns the gene TP53 and astrocytoma (excluding glioblastoma).